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Heterosexual transmission is the leading mode of HIV-1
infection worldwide, with women particularly vulnerable
to HIV-1 infection as they often cannot control sexual
encounters or insist on condom use. In the absence of an
effective vaccine there is an urgent need to develop alter-
native prevention strategies. The immediate events
between exposure to infectious virus and the establish-
ment of infection are still poorly understood. Defining the
mechanisms of HIV-1 transmission, the target cells
involved and how the virus attaches to and fuses with
these cells is revealing new ways to block the sexual spread
of the virus. Initial efforts to develop vaginal microbicides
focused on killing the virus through membrane disrup-
tion using surfactants, and blocking viral entry using poly-
anionic compounds that interact with the positively
charged areas of the viral envelope proteins, many of
which are currently in phase II/III trials. However recent
advances in HIV pathogenesis and therapeutics are now
bringing a wide range of new products into the develop-
ment pipeline that specifically target different stages in the
viral life cycle. This talk will present rigorous pre-clinical
evaluation of candidate microbicides prior to selection for
clinical trials, providing considerable savings in costs and
time, given the expense and length of formal efficacy tri-
als. Selection criteria include: high activity against cell free
and cell associated virus in mucosal explant models; low
irritation potential based on a range of preclinical irrita-
tion assays; high in vitro activity in the presence of semen;
and effectiveness in animal models using challenge virus
that is relevant to sexual HIV transmission. This presenta-
tion discussed how our increasing knowledge of the ways
in which HIV-1 is transmitted has sharpened the develop-
ment of new, more sophisticated intervention strategies
based on the application of vaginal or rectal microbicides.
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